Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
MediPharm Labs Corp. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2027 | $44.28M | $44.28M - $44.28M | -$23.39M | -$0.007 | 1 |
| Dec 2026 | $38.98M | $38.98M - $38.98M | -$20.59M | -$0.008 | 1 |
| Dec 2025 | $45.88M | $45.88M - $45.88M | -$24.24M | -$0.018 | 1 |
| Dec 2024 | $40.82M | $40.82M - $40.82M | -$21.56M | -$0.024 | 1 |
| Dec 2023 | $37.76M | $37.76M - $37.76M | -$19.94M | -$0.033 | 1 |
| Dec 2022 | $22.50M | $22.50M - $22.50M | -$15.73M | -$0.103 | 1 |
| Dec 2021 | $22.00M | $22.00M - $22.00M | -$15.39M | -$0.155 | 1 |
| Dec 2020 | $36.15M | $36.15M - $36.15M | -$25.28M | -$0.282 | 1 |
| Dec 2019 | $131.80M | $131.80M - $131.80M | -$92.16M | $0.048 | 1 |
| Dec 2018 | $9.74M | $9.74M - $9.74M | -$6.81M | -$0.10 | 1 |